Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2018 Jan 31

PMID 29379504

Citations 172

Authors

Elisa Wirthgen

Andreas Hoeflich

Alexander Rebl

Juliane Gunther

Affiliations

Soon will be listed here.

Abstract

Tryptophan metabolites are known to participate in the regulation of many cells of the immune system and are involved in various immune-mediated diseases and disorders. Kynurenic acid (KYNA) is a product of one branch of the kynurenine pathway of tryptophan metabolism. The influence of KYNA on important neurophysiological and neuropathological processes has been comprehensively documented. In recent years, the link of KYNA to the immune system, inflammation, and cancer has become more apparent. Given this connection, the anti-inflammatory and immunosuppressive functions of KYNA are of particular interest. These characteristics might allow KYNA to act as a "double-edged sword." The metabolite contributes to both the resolution of inflammation and the establishment of an immunosuppressive environment, which, for instance, allows for tumor immune escape. Our review provides a comprehensive update of the significant biological functions of KYNA and focuses on its immunomodulatory properties by signaling G-protein-coupled receptor 35 (GPR35)- and aryl hydrocarbon receptor-mediated pathways. Furthermore, we discuss the role of KYNA-GPR35 interaction and microbiota associated KYNA metabolism for gut homeostasis.

Citing Articles

Sensitive Detection of Kynurenic Acid from Biological Fluids Using a Flexible Electrochemical Platform Based on Gold Nanoparticles and Reduced Graphene Oxide.

Macovei D, Tertis M, Bogdan D, Suciu M, Barbu-Tudoran L, Cristea C Int J Mol Sci. 2025; 26(3).

PMID: 39940684 PMC: 11817856. DOI: 10.3390/ijms26030913.

A multidimensional fecal microbial and inflammatory biomarker profiling in preterm and full-term neonates.

Hannawayya R, Puentes R, Mirzadzare N, Cirone K, Amin H, Soraisham A Pediatr Res. 2025; .

PMID: 39856229 DOI: 10.1038/s41390-025-03882-9.

Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism.

Sheng Y, Qiao C, Zhang Z, Shi X, Yang L, Xi R Adv Sci (Weinh). 2024; 12(3):e2409310.

PMID: 39585774 PMC: 11744582. DOI: 10.1002/advs.202409310.

Perturbations of tryptophan catabolism via the kynurenine pathway are associated with stage 2 postoperative outcomes in single ventricle heart disease.

Romanowicz J, Niemiec S, Khailova L, Lehmann T, Mancuso C, Mitchell M Physiol Rep. 2024; 12(22):e70133.

PMID: 39581847 PMC: 11586103. DOI: 10.14814/phy2.70133.

IL-33 Induces a Switch in Intestinal Metabolites Revealing the Tryptophan Pathway as a Target for Inducing Allograft Survival.

Pinto C, Carrasco-Loncharic T, Gonzalez-Mienert E, de Solminihac J, Galvez-Jiron F, Cifuentes F Nutrients. 2024; 16(21).

PMID: 39519488 PMC: 11547499. DOI: 10.3390/nu16213655.

References

Fisher D, Appenheimer M, Evans S . The two faces of IL-6 in the tumor microenvironment. Semin Immunol. 2014; 26(1):38-47. PMC: 3970580. DOI: 10.1016/j.smim.2014.01.008. View

Jauch D, Urbanska E, Guidetti P, BIRD E, Vonsattel J, Whetsell Jr W . Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases. J Neurol Sci. 1995; 130(1):39-47. DOI: 10.1016/0022-510x(94)00280-2. View

Hilmas C, Pereira E, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque E . The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci. 2001; 21(19):7463-73. PMC: 6762893. View

Lugo-Huitron R, Blanco-Ayala T, Ugalde-Muniz P, Carrillo-Mora P, Pedraza-Chaverri J, Silva-Adaya D . On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress. Neurotoxicol Teratol. 2011; 33(5):538-47. DOI: 10.1016/j.ntt.2011.07.002. View

Curto M, Lionetto L, Negro A, Capi M, Fazio F, Giamberardino M . Altered kynurenine pathway metabolites in serum of chronic migraine patients. J Headache Pain. 2016; 17:47. PMC: 4851673. DOI: 10.1186/s10194-016-0638-5. View

Baglole C, Maggirwar S, Gasiewicz T, Thatcher T, Phipps R, Sime P . The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem. 2008; 283(43):28944-57. PMC: 2570856. DOI: 10.1074/jbc.M800685200. View

Kuc D, Zgrajka W, Parada-Turska J, Urbanik-Sypniewska T, Turski W . Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids. 2008; 35(2):503-5. DOI: 10.1007/s00726-007-0631-z. View

Skene D, Papagiannidou E, Hashemi E, Snelling J, Lewis D, Fernandez M . Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices. J Pineal Res. 2001; 31(4):333-42. DOI: 10.1034/j.1600-079x.2001.310408.x. View

Han Q, Robinson H, Cai T, Tagle D, Li J . Biochemical and structural properties of mouse kynurenine aminotransferase III. Mol Cell Biol. 2008; 29(3):784-93. PMC: 2630683. DOI: 10.1128/MCB.01272-08. View

10.

Dobelis P, Staley K, Cooper D . Lack of modulation of nicotinic acetylcholine alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons. PLoS One. 2012; 7(7):e41108. PMC: 3405093. DOI: 10.1371/journal.pone.0041108. View

11.

Wirthgen E, Hoeflich A . Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis. J Amino Acids. 2016; 2015:973548. PMC: 4736209. DOI: 10.1155/2015/973548. View

12.

Blanco Ayala T, Lugo Huitron R, Carmona Aparicio L, Ramirez Ortega D, Gonzalez Esquivel D, Pedraza Chaverri J . Alternative kynurenic acid synthesis routes studied in the rat cerebellum. Front Cell Neurosci. 2015; 9:178. PMC: 4435238. DOI: 10.3389/fncel.2015.00178. View

13.

Han Q, Li J, Li J . pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I. Eur J Biochem. 2004; 271(23-24):4804-14. DOI: 10.1111/j.1432-1033.2004.04446.x. View

14.

Opitz C, Litzenburger U, Sahm F, Ott M, Tritschler I, Trump S . An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 2011; 478(7368):197-203. DOI: 10.1038/nature10491. View

15.

Walczak K, Deneka-Hannemann S, Jarosz B, Zgrajka W, Stoma F, Trojanowski T . Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells. Pharmacol Rep. 2014; 66(1):130-6. DOI: 10.1016/j.pharep.2013.06.007. View

16.

Bessede A, Gargaro M, Pallotta M, Matino D, Servillo G, Brunacci C . Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature. 2014; 511(7508):184-90. PMC: 4098076. DOI: 10.1038/nature13323. View

17.

Stone T . Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats. Eur J Neurosci. 2007; 25(9):2656-65. DOI: 10.1111/j.1460-9568.2007.05540.x. View

18.

Werner E, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G . Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci. 1987; 41(3):273-80. DOI: 10.1016/0024-3205(87)90149-4. View

19.

Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan T . The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008; 43(2):164-74. DOI: 10.1016/j.jpsychires.2008.03.009. View

20.

Gkotsos G, Virgiliou C, Lagoudaki I, Sardeli C, Raikos N, Theodoridis G . The Role of Sarcosine, Uracil, and Kynurenic Acid Metabolism in Urine for Diagnosis and Progression Monitoring of Prostate Cancer. Metabolites. 2017; 7(1). PMC: 5372212. DOI: 10.3390/metabo7010009. View